Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1775 of 2873 entries
View as:

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00984997 Org: User:
Start: 10/31/93 End: 06/30/15 Due: 06/30/16

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00628628 Org: User:
Start: 01/31/08 End: 05/31/12 Due: 05/31/13

Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01919619 Org: User:
Start: 11/04/13 End: 05/03/24 Due: 05/03/25

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004136 Org: User:
Start: 03/09/98 End: 01/25/06 Due: 01/25/07

Determinants of Smoking Cessation Among Latinos

Phase: N/A Priority: Normal
NCT ID: NCT01008748 Org: User:
Start: 09/30/09 End: 09/30/16 Due: 09/30/17

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01786343 Org: User:
Start: 02/05/13 End: 05/06/19 Due: 05/06/20

Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT04785534 Org: User:
Start: 12/22/20 End: 08/31/26 Due: 08/31/27

Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT03873818 Org: User:
Start: 02/21/19 End: 08/31/26 Due: 08/31/27

Caphosol in Sarcoma Patients With Mucositis

Phase: N/A Priority: Normal
NCT ID: NCT00965172 Org: User:
Start: 04/30/10 End: 02/29/12 Due: 02/28/13

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

Phase: N/A Priority: Normal
NCT ID: NCT05054400 Org: User:
Start: 02/05/20 End: 08/29/23 Due: 08/29/24

Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00476229 Org: User:
Start: 06/30/06 End: 05/31/09 Due: 05/31/10

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04003038 Org: User:
Start: 05/02/19 End: 04/30/26 Due: 04/30/27

Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03672539 Org: User:
Start: 11/07/18 End: 11/30/25 Due: 11/30/26

Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT00899431 Org: User:
Start: 05/06/09 End: 10/07/18 Due: 10/07/19

Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01955460 Org: User:
Start: 10/15/14 End: 10/30/27 Due: 10/30/28

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01893320 Org: User:
Start: 07/18/13 End: 01/11/21 Due: 01/11/22

Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00067639 Org: User:
Start: 12/31/03 End: 04/30/07 Due: 04/30/08

CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02027935 Org: User:
Start: 01/22/15 End: 04/12/24 Due: 04/12/25

Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03622788 Org: User:
Start: 08/08/19 End: 12/01/25 Due: 12/01/26

Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD

Phase: N/A Priority: Normal
NCT ID: NCT00038792 Org: User:
Start: 10/31/00 End: 01/31/03 Due: 01/31/04

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

Phase: N/A Priority: Normal
NCT ID: NCT00685568 Org: User:
Start: 11/21/02 End: 04/21/06 Due: 04/21/07

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06401603 Org: User:
Start: 08/06/24 End: 01/01/29 Due: 01/01/30

Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02754752 Org: User:
Start: 09/13/16 End: 12/31/26 Due: 12/31/27

Intraoperative Aromatherapy Versus Placebo for Port-a-Cath Placement Under Monitored Anesthesia Care. A Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT05328973 Org: User:
Start: 05/18/22 End: 01/16/24 Due: 01/16/25

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00353145 Org: User:
Start: 02/29/04 End: 01/31/10 Due: 01/31/11